Shop

Showing 913–928 of 1236 results

Article: P.13 Tumour Databanking in Belgium: a central role for the BVT, the nationwide Belgian Virtual Tumourbank
€3.03 Only for registered clients
Article: P.13 UNEXPECTED TOXICITY IN A PATIENT TREATED WITH FLUOROPYRIMIDINES FOR A METASTATIC BREAST CANCER
€3.03 Only for registered clients
Article: P.14 Launching ‘NETwerk’: diagnosis and treatment of neuroendocrine tumors within a multi-institutional collaboration in the region of Antwerp-Waasland in Belgium
€3.03 Only for registered clients
Article: P.14 METASTATIC MELANOMA: CURED BY SURGERY OR DELAYED IMMUNOTHERAPY RESPONSE
€3.03 Only for registered clients
Article: P.15 Abiraterone acetate associated rhabdomyolysis
€3.03 Only for registered clients
Article: P.15 ABOUT A COMBINATION OF LOWER ESOPHAGEAL CANCER AND SECONDARY CEREBRAL LOCALIZATION
€3.03 Only for registered clients
Article: P.16 ABOUT A CASE: MALE BREAST CANCER WITH PULMONARY METASTASES AND THERAPEUTIC RESPONSE TO EVEROLIMUS+EXEMESTANE
€3.03 Only for registered clients
Article: P.17 PROGRAMMED CELL DEATH-1 (PD-1) INHIBITORS: DON’T FORGET TYPE 1 DIABETES MELLITUS! A CASE REPORT
€3.03 Only for registered clients
Article: P.18 QUALITY OF LIFE, FATIGUE, AND SUBJECTIVE COGNITIVE FUNCTIONING IMMEDIATELY AND 6 MONTHS AFTER ADJUVANT CHEMOTHERAPY IN BREAST CANCER PATIENTS
€3.03 Only for registered clients
Article: P.19 A-105 WHEN DRUG TOXICITIES ARE DRIVEN BY SOCIAL HABITS: A CASE REPORT
€3.03 Only for registered clients
Article: P01 PARANEOPLASTIC OPTIC NEURITIS IN LUNG ADENOCARCINOMA: A CASE REPORT
€3.03 Only for registered clients
Article: P02 WHEN PNEUMATURIA IS ASSOCIATED WITH METASTATIC LUNG CANCER DIAGNOSIS
€3.03 Only for registered clients
Article: P03 EVALUATION OF QUALITY OF CARE FOR NEUROENDOCRINE TUMORS IN LIMBURG
€3.03 Only for registered clients
Article: P04 BASELINE CHARACTERISTICS AND PROGRESSION-FREE SURVIVAL OF THE BELGIAN COHORT FROM THE PACIFIC-R TRIAL
€3.03 Only for registered clients
Article: P05 ISOLATED UTERINE METASTASIS OF INVASIVE DUCTAL CARCINOMA MIMICKING A TAMOXIFEN INDUCED UTERINE HYPERPLASIA
€3.03 Only for registered clients
Article: P06 COMPLETENESS AND SELECTION BIAS OF A BELGIAN MULTIDISCIPLINARY, REGISTRATION-BASED STUDY ON THE EFFECTIVENESS AND QUALITY OF ENDOMETRIAL CANCER TREATMENT (EFFECT)
€3.03 Only for registered clients

Article: P.13 Tumour Databanking in Belgium: a central role for the BVT, the nationwide Belgian Virtual Tumourbank

Article: P.13 UNEXPECTED TOXICITY IN A PATIENT TREATED WITH FLUOROPYRIMIDINES FOR A METASTATIC BREAST CANCER

Article: P.14 Launching ‘NETwerk’: diagnosis and treatment of neuroendocrine tumors within a multi-institutional collaboration in the region of Antwerp-Waasland in Belgium

Article: P.14 METASTATIC MELANOMA: CURED BY SURGERY OR DELAYED IMMUNOTHERAPY RESPONSE

Article: P.15 Abiraterone acetate associated rhabdomyolysis

Article: P.15 ABOUT A COMBINATION OF LOWER ESOPHAGEAL CANCER AND SECONDARY CEREBRAL LOCALIZATION

Article: P.16 ABOUT A CASE: MALE BREAST CANCER WITH PULMONARY METASTASES AND THERAPEUTIC RESPONSE TO EVEROLIMUS+EXEMESTANE

Article: P.17 PROGRAMMED CELL DEATH-1 (PD-1) INHIBITORS: DON’T FORGET TYPE 1 DIABETES MELLITUS! A CASE REPORT

Article: P.18 QUALITY OF LIFE, FATIGUE, AND SUBJECTIVE COGNITIVE FUNCTIONING IMMEDIATELY AND 6 MONTHS AFTER ADJUVANT CHEMOTHERAPY IN BREAST CANCER PATIENTS

Article: P.19 A-105 WHEN DRUG TOXICITIES ARE DRIVEN BY SOCIAL HABITS: A CASE REPORT

Article: P01 PARANEOPLASTIC OPTIC NEURITIS IN LUNG ADENOCARCINOMA: A CASE REPORT

Article: P02 WHEN PNEUMATURIA IS ASSOCIATED WITH METASTATIC LUNG CANCER DIAGNOSIS

Article: P03 EVALUATION OF QUALITY OF CARE FOR NEUROENDOCRINE TUMORS IN LIMBURG

Article: P04 BASELINE CHARACTERISTICS AND PROGRESSION-FREE SURVIVAL OF THE BELGIAN COHORT FROM THE PACIFIC-R TRIAL

Article: P05 ISOLATED UTERINE METASTASIS OF INVASIVE DUCTAL CARCINOMA MIMICKING A TAMOXIFEN INDUCED UTERINE HYPERPLASIA

Article: P06 COMPLETENESS AND SELECTION BIAS OF A BELGIAN MULTIDISCIPLINARY, REGISTRATION-BASED STUDY ON THE EFFECTIVENESS AND QUALITY OF ENDOMETRIAL CANCER TREATMENT (EFFECT)